The LoF in BLIMP1 could directly cause deletions and disruptive mutations usually observed in 25% of DLBCL patients or indirectly by BCL6 deregulation through suppression seen in 25% of DLBCL patients [92]. Here, BCL6 is linked to diffuse large B-cell lymphoma.